Skip to content
Shorla Oncology: A Leader in Innovative Oncology Solutions
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • TEPYLUTE
    • IMKELDI
    • JYLAMVO
    • Nelarabine Injection
  • Pipeline
  • News
    • Company Updates
    • Media
  • Careers
  • Contact
September 30th 2025June 20th 2025

Oncology Key Account Manager – South

Help bring life-changing cancer treatments to patients who need them most.

At Shorla Oncology, patients are at the heart of everything we do. Guided by compassion, innovation, and collaboration, we develop affordable, accessible oncology medicines that make a meaningful difference for underserved populations. We’re growing with purpose, bringing together people who share our compassion and determination, and who are motivated by the chance to improve patients’ lives.

We’re now hiring an Oncology Key Account Manager to join our expanding U.S. team in the South region.

This territory includes Mississippi, Tennessee, Missouri, Kansas, Texas, Oklahoma, Arkansas, and Louisiana. Candidates based in Texas or Nashville are strongly preferred, given the proximity to a large concentration of key accounts and from these locations, travel requirements are expected to be approximately 25% of the time.

This position is field-based and reports to the Vice President, Sales & Account Management. It offers the chance to play a pivotal part in shaping Shorla’s commercial success while expanding patient access to our oncology portfolio.

Apply Now

Your Impact

In this role, you will:

  • Develop and deliver a regional account strategy that drives growth and market penetration across cancer centers, academic medical centers, hospitals, IDNs, and large community oncology practices.
  • Build strategic account plans covering EHR protocol development, inclusion in dispensing systems, formulary placement, and identification of key decision-makers.
  • Conduct regular in-person visits to support contract pull-through, share clinical insights, and strengthen relationships with stakeholders.
  • Establish trusted partnerships with clinical and administrative leaders, including procurement teams.
  • Collaborate with Market Access to maximize GPO pull-through and triage contracting opportunities.
  • Work cross-functionally with Sales, Marketing, Medical Affairs, and Market Access to communicate the value and differentiation of Shorla’s products.
  • Stay ahead of industry trends, competitive shifts, and regulatory updates affecting oncology practice.
  • Represent Shorla Oncology at regional industry conferences, trade shows, and networking events.
  • Track key performance metrics and provide market insights to leadership.
  • Ensure full compliance with all relevant pharmaceutical regulations and Shorla Oncology SOPs.

What you’ll bring to the team:

You’ll succeed in this role if you bring:

  • A BA/BS degree (Master’s preferred).
  • 5+ years of proven oncology sales success, ideally with hospitals, IDN’s, academic centers, or large community practices. Prior oncology product launch experience is a plus.
  • Knowledge of oncology product distribution, purchasing, and GPOs.
  • Pre-existing relationships with key oncology accounts (highly desirable).
  • Strong account management, negotiation, and relationship-building skills within matrixed healthcare systems.
  • Superior selling skills — planning, probing, challenging, closing, and following up with clinical staff.
  • Excellent communication skills, with professional English fluency.
  • Independence, resilience, and the ability to thrive in a fast-paced, entrepreneurial environment.
  • Proficiency in Microsoft Office and CRM platforms.
  • Willingness to travel extensively within the assigned territory (approx. 25% when based near key accounts or hubs in the South).

Why Shorla?

At Shorla, you’ll join a motivated, energetic team where collaboration and camaraderie drive success. We offer a competitive salary and an attractive range of benefits, including:

  • Discretionary performance bonus scheme
  • Medical, vision, and dental coverage
  • 401(k) with company contributions
  • Long-term and short-term disability insurance
  • Generous paid time off
  • Hybrid working options.
  • Continuous learning and career growth opportunities.

More than a job, this is your chance to be part of a growing, mission-driven company that’s redefining what’s possible in oncology care.

If this role feels like the right fit for you, we’d love to hear from you. Join us at Shorla Oncology and help us bring meaningful cancer treatments to patients who need them most.

Inclusion & Diversity

Shorla Oncology is proud to be an inclusive employer. Employment is governed by merit, competence, and qualifications and is not influenced by race, color, religion, gender, national origin/ethnicity, veteran status, disability status, age, sexual orientation, gender identity, marital status, mental or physical disability, or any other legally protected status.

Apply Now

Logo

IRELAND HQ:
Questum Acceleration Center,
Ballingarrane Science & Technology Park,
Clonmel, Co. Tipperary,
E91 V329, Ireland

Shorla Pharma Ltd trading as Shorla Oncology®

All trademarks are the property of their respective owners.

US OFFICE:
245 Main St.,
2nd floor,
Cambridge,
MA 02142, USA

SITEMAP

PRIVACY POLICY

CALIFORNIA COMPLIANCE PROGRAM DECLARATION

Company number: 618033
©SHORLA ONCOLOGY® 2025

© 2025 Shorla Oncology: A Leader in Innovative Oncology Solutions • Built with GeneratePress
  • About Us
    • Executive Team
    • Leadership Team
    • Board of Directors
    • Advisory Team
  • Products
    • TEPYLUTE
    • IMKELDI
    • JYLAMVO
    • Nelarabine Injection
  • Pipeline
  • News
    • Company Updates
    • Media
  • Careers
  • Contact

Now approved for use in Pediatrics

  • Treatment of pediatric patients with polyarticular juvenile idiopathic arthritis (pJIA).
  • Treatment of pediatric patients with acute lymphoblastic leukemia (ALL) as part of a combination chemotherapy maintenance regimen.

Please click here for the full Prescribing information, including Boxed Warning regarding embryo-fetal toxicity, hypersensitivity reactions, and severe adverse reactions.